期刊文献+

特非那丁不良反应概况及在我国的应用前景

下载PDF
导出
出处 《中国药事》 CAS 2000年第3期195-197,共3页 Chinese Pharmaceutical Affairs
  • 相关文献

参考文献8

  • 11,FDA proposes to withdrawSeldane approval.Reactions,1997,634:2
  • 2孙定人 王土凡 等.药物不良反应[M].北京:人民卫生出版社,1996.113.
  • 33,Marion Merrell Dows. Seldane contraindicated in patients receiving erythromycin:safetyquestions may spell &127;end for OTC Seldane submission.FDC Reports the PinkSheet,1992,54:9
  • 44,Burkhart GA,Sevka MJ,Temple R,Honig PK.Temporal decline in filling prescriptions forterfenadine closely in time with those for either ketoconazole or erythromycin.ClinicalPharmacology and Therapeutics,1997,61:93
  • 55,Pratt CM,Hertz RP,Ellis BE, el al.Risk of developing life-threatening ventriculararrhythmia associated with terfenadine in comparison with over-the-counter antihistamines,ibuprofen and clemastine.American-Journal-of-Cardiology,1994,73 :346
  • 66  Hanrahan JP,Choo PW,Carlson W, et al. Terfenadine-associated ventricular , andQTC interal prolongation :a retrospective cohort comparison with other antihistaminesamong members of a health maintenance organization. Annals-of-Epidemiology,1995,5:201
  • 77,中国生物医学文献光盘数据库(CBMDISC).特非那丁,1982,1-1997,6
  • 88,MEDLINE生物医学文献光盘数据库.terfenadine,1983,1-1997,12

共引文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部